Prospective Evaluation of the Use of Thunderbeat Vessel Sealing Device in Laparoscopic Surgery

N/AUnknownNCT01999296

Cantonal Hosptal, Baselland250 enrolled

Overview

All patients undergoing laparoscopic visceral and gynecologic procedures using the combined bipolar and ultrasonic vessel sealing and dissection device Thunderbeat are entered in a prospective registry. Data will be analysed concerning the safe use of the instrument and perioperative blood loss.

Study Type

OBSERVATIONAL

Enrollment

250

Conditions

Indication for Laparoscopic Surgery (Any)

Interventions

Use of Thunderbeat (TM) in laparoscopic surgeryDEVICE

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * all patients undergoing laparoscopic visceral or gynecologic surgery * need for a vessel sealing device during surgery Exclusion Criteria: * non able to understand informed consent or missing consent * age \<18

Locations (1)

Kantonsspital Baselland Bruderholz

Bruderholz, Switzerland

Outcomes

Primary Outcomes

Intra- and postoperative device-related complications

Time frame: 30 days

Use of additional vessel sealing devices

Time frame: one day

Secondary Outcomes

Perioperative Blood Loss

Time frame: 30 days

Duration of Surgery

Time frame: one day

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.